BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 1500025)

  • 1. Pharmacokinetics and pharmacodynamics of intraperitoneal cancer chemotherapeutics.
    Hasovits C; Clarke S
    Clin Pharmacokinet; 2012 Apr; 51(4):203-24. PubMed ID: 22420577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-look laparotomy for epithelial ovarian cancer: a reappraisal.
    Chu CS; Rubin SC
    Curr Oncol Rep; 2001 Jan; 3(1):11-8. PubMed ID: 11123864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraperitoneal chemotherapy with cisplatin and etoposide in ovarian carcinoma patients who are clinically in complete remission.
    Menczer J; Ben-Baruch G; Rizel S; Brenner H
    Eur J Gynaecol Oncol; 1995; 16(1):12-7. PubMed ID: 7744111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma.
    Piver MS; Lele SB; Marchetti DL; Baker TR; Emrich LJ; Hartman AB
    J Clin Oncol; 1988 Nov; 6(11):1679-84. PubMed ID: 3183700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of ifosfamide and cisplatinum in advanced ovarian cancer.
    Aziz Z; Zahid M; Ud Din Ahmed Z; Arshad T
    Aust N Z J Med; 1998 Jun; 28(3):403-9. PubMed ID: 9673759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal cisplatin chemotherapy versus abdominopelvic irradiation in ovarian carcinoma patients after second look laparotomy. A reassessment based on mature data.
    Ben-Baruch G; Menczer J; Feldman B; Rizel S; Brenner H
    Eur J Gynaecol Oncol; 1994; 15(4):272-6. PubMed ID: 7957334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal cisplatin chemotherapy versus abdominopelvic irradiation in ovarian carcinoma patients after second-look laparotomy.
    Menczer J; Ben-Baruch G; Modan M; Brenner H
    Cancer; 1989 Apr; 63(8):1509-13. PubMed ID: 2924259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal cisplatin chemotherapy in ovarian carcinoma patients who are clinically in complete remission.
    Menczer J; Ben-Baruch G; Rizel S; Brenner H
    Gynecol Oncol; 1992 Aug; 46(2):222-5. PubMed ID: 1500025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T; Vance R; Puneky L; Khansur T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal cisplatin-based chemotherapy for ovarian carcinoma.
    Howell SB; Kirmani S; McClay EF; Kim S; Braly P; Plaxe S
    Semin Oncol; 1991 Feb; 18(1 Suppl 3):5-10. PubMed ID: 2003227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy in advanced ovarian cancer.
    Rodenburg CJ; Cleton FJ
    J Cancer Res Clin Oncol; 1984; 107(2):99-105. PubMed ID: 6371017
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.